Experimentally Induced Mood Changes Preferentially Affect Pain Unpleasantness

2008 ◽  
Vol 9 (9) ◽  
pp. 784-791 ◽  
Author(s):  
Marco L. Loggia ◽  
Jeffrey S. Mogil ◽  
M. Catherine Bushnell
Pain ◽  
1981 ◽  
Vol 11 ◽  
pp. S279 ◽  
Author(s):  
Philip M. Toyama ◽  
Clara Heyder

2017 ◽  
Vol 75 ◽  
pp. 237-240 ◽  
Author(s):  
Randip Taneja ◽  
Krystal Hunter ◽  
Evren Burakgazi-Dalkilic ◽  
Melissa Carran

1955 ◽  
Vol 157 (13) ◽  
pp. 1113 ◽  
Author(s):  
John M. von Felsinger

2018 ◽  
Vol 215 (3) ◽  
pp. 519-527 ◽  
Author(s):  
Divya Mehta ◽  
Monika Rex-Haffner ◽  
Helle Bach Søndergaard ◽  
Anja Pinborg ◽  
Elisabeth B. Binder ◽  
...  

BackgroundEnhanced sensitivity to oestrogen signalling may drive increased risk for depressive symptoms when exposed to peripartum sex-steroid hormone fluctuations.AimTesting if 116 pre-identified sex steroid-responsive transcripts that predicted perinatal depression (PND) translates to a pharmacological model of hormone-induced mood changes.MethodWe generated longitudinal, genome-wide gene-expression and DNA-methylation data from 60 women exposed to a gonadotrophin-releasing hormone agonist (GnRHa) or placebo. We used linear mixed-effect models to assess differences between baseline and follow-up for gene expression and DNA methylation in the biphasic ovarian response to GnRHa.ResultsOf the 116 PND-predictive transcripts, a significant (19%) overlap was observed with those differentially expressed post-GnRHa at both early and later follow-up, indicating sustained effects. Similarly, 49% of tested genes were differentially methylated post-GnRHa at the late follow-up. Within the GnRHa group, a large proportion of PND genes were significantly associated (gene expression; DNA methylation) with changes in depressive symptoms (28%; 66%), oestradiol levels (49%; 66%) and neocortex serotonin transporter binding (8%; 45%) between baseline and follow-up.ConclusionsOur data bridge clinical PND biomarkers with a pharmacological model of sex hormone-induced mood changes and directly relate oestrogen-induced biological changes with depressive symptoms and associated serotonin-signalling changes. Our data highlight that individual variations in molecular sensitivity to oestrogen associate with susceptibility to hormone-induced mood changes and hold promise for candidate biomarkers.Declaration of interestV.G.F. received honorarium for being a speaker for H. Lundbeck A/S. E.B.B. receives research funding from Böhringer Ingelheim to investigate FKBP5 as a potential drug target for depression.


Appetite ◽  
2007 ◽  
Vol 49 (3) ◽  
pp. 667-674 ◽  
Author(s):  
Michael Macht ◽  
Jochen Mueller

1982 ◽  
Vol 17 (2) ◽  
pp. 147-154 ◽  
Author(s):  
Peter D. Leathwood ◽  
Patricia Pollet

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Anna M. Polaski ◽  
Amy L. Phelps ◽  
Kimberly A. Szucs ◽  
Austin M. Ramsey ◽  
Matthew C. Kostek ◽  
...  

Abstract Knowledge of efficacious dosing respective to exercise type and pain condition is extremely limited in the literature. This study aimed to determine the impact of dose of moderate intensity treadmill walking on experimentally-induced pain in healthy human participants. Forty females were divided into 4 groups: control (no exercise), low dose exercise (3×/wk), moderate dose exercise (5×/wk) or high dose exercise (10×/wk). Over a 7-day period, subjects performed treadmill walking during assigned exercise days. Both qualitative and quantitative measures of pain were measured at baseline, during the trial, and 24 hrs post-final intervention session via sensitivity thresholds to painful thermal and painful pressure stimulation. Significant effects of treatment were found post-intervention for constant pressure pain intensity (p = 0.0016) and pain unpleasantness ratings (p = 0.0014). Post-hoc tests revealed significant differences between control and moderate and control and high dose groups for constant pressure pain intensity (p = 0.0015), (p = 0.0094), respectively and constant pressure pain unpleasantness (p = 0.0040), (p = 0.0040), respectively. Moderate and high dose groups had the greatest reductions in ratings of pain, suggesting that our lowest dose of exercise was not sufficient to reduce pain and that the moderate dose of exercise may be a sufficient starting dose for exercise-based adjuvant pain therapy.


2012 ◽  
Vol 17 (2) ◽  
pp. 69-74 ◽  
Author(s):  
Chantal Villemure ◽  
Audrey C Laferrière ◽  
M Catherine Bushnell

BACKGROUND: The ventral striatum, particularly the nucleus accumbens, is commonly associated with the processing of reward and positive stimuli, positive affect as well as antinociceptive processes.OBJECTIVES: The present study examined whether the ventral striatum is implicated in analgesia resulting from positive mood change induced by pleasant odours.METHODS: Functional magnetic resonance imaging studies were conducted in healthy individuals receiving painful heat stimuli in the presence of pleasant or unpleasant odours, which were used to induce positive and negative mood states. Ventral striatum activity was examined in the two mood states.RESULTS: For most subjects, pleasant odours improved mood and reduced pain unpleasantness perception relative to unpleasant odours. In the pleasant odour condition, the maximum activation of both the left and right ventral striatum was positively correlated with the amount of pain reduction. Furthermore, the left and right ventral striatum activations positively covaried with one another, and the right ventral striatum activation positively correlated with that in the periaqueductal grey matter. Both ventral striatum activations negatively covaried with the activation of the right mediodorsal thalamus, left dorsal anterior cingulate cortex, left medial prefrontal cortex and right ventrolateral prefrontal cortex.CONCLUSIONS: Because both the mediodorsal thalamus and anterior cingulate are involved in pain affect perception, and activation within the prefrontal areas and periaqueductal grey matter were previously shown to correlate with mood-related pain modulation, it is concluded that the ventral striatum is likely implicated in the analgesic effect of positive mood changes induced by pleasant odours on pain unpleasantness.


2002 ◽  
Vol 47 (6) ◽  
pp. 603-609 ◽  
Author(s):  
S. E. Gowans ◽  
A. deHueck ◽  
S. E. Abbey

Sign in / Sign up

Export Citation Format

Share Document